InsiderTrades

Form 4 for LUNG Pulmonx Corp

Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001805624-25-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-12-03 2025-12-01 LUNG French Glendon E. III Pres, CEO, Dir S - Sale $1.57 -8,805 277.3K -3% -$13.8K
D 2025-12-03 2025-12-01 LUNG French Glendon E. III Pres, CEO, Dir A - Grant $0.00 +1.20M 1.48M +433% $0
D 2025-12-03 2025-12-01 LUNG French Glendon E. III Pres, CEO, Dir A - Grant $0.00 +800.0K 800.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-01 S D 2,524 $1.57 283,605 D — —
2 Common Common Stock 2025-12-01 A A 1,200,000 $0.00 1,477,324 D — — (F3) Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
3 Common Common Stock 2025-12-01 S D 6,281 $1.57 277,324 D — —
4 Derivative Performance Stock Units 2025-12-01 A A 800,000 $0.00 800,000 D — · — to 2028-12-01 800,000 Common Stock (F5) Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments.